Joint Health Ingredient
N-Acetyl Glucosamine Powder Supplier
N-Acetyl-D-Glucosamine (GlcNAc / NAG) powder for joint-health and specialty supplement formulations. Gensei supplies N-acetyl glucosamine for commercial ingredient sourcing, with product identity and technical information available for project discussions.
Identität der Inhaltsstoffe
N-Acetyl-D-Glucosamine Product Details
Chemical identity and common naming used for GlcNAc / NAG.
Ingredient Comparison
GlcNAc, Glucosamine HCl & Glucosamine Sulfate
These are distinct glucosamine forms and should be identified by the exact ingredient specified in the finished formula.
| Attribut | GlcNAc / NAG | Glucosamin HCl | Glucosamin-Sulfat |
|---|---|---|---|
| Chemische Form | N-Acetyl-D-Glucosamin | Glucosamine hydrochloride | Glucosamin-Sulfat |
| Schwerpunkt der Spezifikation | Identity, assay, source, particle size and supporting documents | Salt identity, assay and applicable specification | Sulfate form, assay and applicable specification |
| Formula use | Select when the formula calls for GlcNAc | Select when the formula calls for glucosamine HCl | Select when the formula calls for glucosamine sulfate |
Technical Reference
GlcNAc Technical Specification Reference
Technical points that may vary by selected grade or production route should be confirmed against the applicable product specification.
| Parameter | Reference / Review Point | Basis |
|---|---|---|
| USP-NF Assay Reference | 98.0%–102.0%, calculated on the dried basis | Pharmacopeial reference |
| Batch Assay | Confirm on the applicable GlcNAc COA for the selected material. | Batch specific |
| Partikelgröße | Confirm the particle-size specification required for the finished dosage form. | Product specific |
| Source & Allergen | Confirm the production source and supporting allergen declaration for the selected material. | Source specific |
Source & Allergen Review
Source & Allergen Considerations
The production route affects source and allergen documentation, so the specific material should be matched to the intended product positioning.
Quelle im Zusammenhang mit Schalentieren
When the production route is linked to crustacean-derived materials, review the source, species information, allergen statement and cross-contact information before making shellfish-related label decisions.
Fermentierung / Quelle: keine Schalentiere
Some GlcNAc suppliers use fermentation or other non-shellfish routes. The production route, substrate and supporting declarations should be verified for the specific material before using vegan, shellfish-free or similar positioning.
Formulierung
N-Acetyl Glucosamine Formulation Formats
GlcNAc powder can be considered across several supplement formats, with processing needs determined by the complete formulation.
Kapseln
For capsule products, serving size, particle characteristics, powder flow and blend uniformity influence the finished manufacturing process.
Tabletten
Tablet development may need to account for compression behavior, excipient compatibility and the physical characteristics of the complete blend.
Gummies & Chewables
For gummies and chewables, formulation development should account for heat exposure, moisture, pH, taste and active stability.
Powder & Drink Formats
For powder blends and drink formats, dispersion, flavor compatibility, moisture protection and blend uniformity are relevant to finished-product performance.
Human Research
Human Research on N-Acetyl Glucosamine
Human studies have evaluated oral N-acetyl glucosamine in relation to cartilage-metabolism biomarkers and joint-related outcomes. Study design, dose and whether GlcNAc was used alone or in combination are important when interpreting the findings for finished supplements.
Cartilage-Metabolism Biomarkers
A randomized, double-blind, placebo-controlled study evaluated 500 mg/day and 1,000 mg/day of GlcNAc for 16 weeks in healthy adults without arthritis symptoms. The study assessed C2C, PIICP and the C2C/PIICP ratio.
GlcNAc + Chondroitin
A randomized, double-blind, placebo-controlled trial examined a combination of N-acetyl glucosamine and chondroitin sulfate in Japanese adults with knee pain or stiffness. The reported outcomes included self-reported knee function and pain-related measures.
GlcNAc + Proteoglycan
A 12-week open study evaluated a tablet containing GlcNAc and proteoglycan in subjects with knee pain, using VAS, JKOM and JOA outcomes.
Project Support
Technical & Commercial Support
Additional product and project information can be coordinated as your formulation moves toward commercial sourcing.
Product Information
Request available technical information for the GlcNAc material being discussed.
Formulation Discussion
Discuss the intended dosage form and any material characteristics relevant to the formulation.
Commercial Coordination
Continue quantity, quotation and purchasing discussions directly with the Gensei team.
Regulatory Reference
Market & Regulatory Considerations
Requirements for GlcNAc can vary with intended use, production source and destination market.
Vereinigte Staaten
USP-NF includes a N-Acetylglucosamine monograph that can serve as a pharmacopeial quality reference. A monograph is not, by itself, authorization of a finished supplement.
Europäische Union
The European Commission's 2026 public Novel Food application list includes an application for N-acetylglucosamine from Shandong Runhan Biotechnology Co., Ltd. This should not be interpreted as a blanket authorization for every GlcNAc material or use.
Discuss Your GlcNAc Ingredient Project
Send your project details and our team will follow up directly to continue the ingredient and commercial discussion.
Inquiry Review
Your message is routed for product and commercial follow-up.
Direct Follow-Up
A member of our team responds to continue the discussion with you.
Next-Step Coordination
Further requests can be coordinated directly as the project moves forward.
Senden Sie Ihre Anfrage
Send us your company details and GlcNAc requirement.